Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Douer

Showing results (21-30 of 86) with videos related to

Pageof 9
Sort By:
Clinical Advances in Hematology & Oncology : H&O|March 24, 2016
Novel Approaches for the Interim Management of Relapsed/Refractory Acute Lymphocytic Leukemia: A Case-Study CompendiumEunice S Wang, Elias J Jabbour, Dan Douer
Blood Reviews|January 15, 2022
Optimizing use of L-asparaginase-based treatment of adults with acute lymphoblastic leukemiaDan Douer, Nicola Gökbuget, Wendy Stock, et al.
Acta Haematologica|April 20, 2011
Therapy-related acute myeloid leukemia following treatment with trabectedin for Ewing's sarcomaStephen V Liu, Susan Zneimer, Amir Tahbaz, et al.
Clinical Advances in Hematology & Oncology : H&O|March 14, 2015
Advances in the treatment of relapsed/refractory acute lymphoblastic leukemia: a case study compendiumGail J Roboz, Elias J Jabbour, Stefan Faderl, et al.
The Oncologist|April 17, 2003
Arsenic trioxide (trisenox) therapy for acute promyelocytic leukemia in the setting of hematopoietic stem cell transplantationDan Douer, Wendy Hu, Sergio Giralt, et al.
Blood|July 29, 2011
How I treat extramedullary acute myeloid leukemiaRichard L Bakst, Martin S Tallman, Dan Douer, et al.
Blood Reviews|August 22, 2018
The emerging story of acute lymphoblastic leukemia among the Latin American population - biological and clinical implicationsElisa Quiroz, Ibrahim Aldoss, Vinod Pullarkat, et al.
ESMO Open|October 10, 2020
Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open-Cancer Horizons roundtable discussionPatrick W Burke, Dieter Hoelzer, Jae H Park, et al.
Cancer Chemotherapy and Pharmacology|May 11, 2025
Pharmacokinetic profile of novel reduced-dose Danziten<sup>™</sup> (nilotinib tablets) versus Tasigna<sup>®</sup> (nilotinib capsules): in vivo bioequivalence and population pharmacokinetic analysisMichael Mauro, Jerald Radich, Paras Jain, et al.
Journal of Translational Medicine|May 21, 2008
Multilineage hematopoietic recovery with concomitant antitumor effects using low dose Interleukin-12 in myelosuppressed tumor-bearing miceLena A Basile, Timothy K Gallaher, Darryl Shibata, et al.
Pageof 9

Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
Clinical Advances in Hematology & Oncology : H&O|March 24, 2016
Novel Approaches for the Interim Management of Relapsed/Refractory Acute Lymphocytic Leukemia: A Case-Study CompendiumEunice S Wang, Elias J Jabbour, Dan Douer
Blood Reviews|January 15, 2022
Optimizing use of L-asparaginase-based treatment of adults with acute lymphoblastic leukemiaDan Douer, Nicola Gökbuget, Wendy Stock, et al.
Acta Haematologica|April 20, 2011
Therapy-related acute myeloid leukemia following treatment with trabectedin for Ewing's sarcomaStephen V Liu, Susan Zneimer, Amir Tahbaz, et al.
Clinical Advances in Hematology & Oncology : H&O|March 14, 2015
Advances in the treatment of relapsed/refractory acute lymphoblastic leukemia: a case study compendiumGail J Roboz, Elias J Jabbour, Stefan Faderl, et al.
The Oncologist|April 17, 2003
Arsenic trioxide (trisenox) therapy for acute promyelocytic leukemia in the setting of hematopoietic stem cell transplantationDan Douer, Wendy Hu, Sergio Giralt, et al.
Blood|July 29, 2011
How I treat extramedullary acute myeloid leukemiaRichard L Bakst, Martin S Tallman, Dan Douer, et al.
Blood Reviews|August 22, 2018
The emerging story of acute lymphoblastic leukemia among the Latin American population - biological and clinical implicationsElisa Quiroz, Ibrahim Aldoss, Vinod Pullarkat, et al.
ESMO Open|October 10, 2020
Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open-Cancer Horizons roundtable discussionPatrick W Burke, Dieter Hoelzer, Jae H Park, et al.
Cancer Chemotherapy and Pharmacology|May 11, 2025
Pharmacokinetic profile of novel reduced-dose Danziten<sup>™</sup> (nilotinib tablets) versus Tasigna<sup>®</sup> (nilotinib capsules): in vivo bioequivalence and population pharmacokinetic analysisMichael Mauro, Jerald Radich, Paras Jain, et al.
Journal of Translational Medicine|May 21, 2008
Multilineage hematopoietic recovery with concomitant antitumor effects using low dose Interleukin-12 in myelosuppressed tumor-bearing miceLena A Basile, Timothy K Gallaher, Darryl Shibata, et al.
Pageof 9